Growth Factor Manipulation of Intestinal Angiogenesis: A Possible New Paradigm in the Management of Inflammatory Bowel Disease

Journal of Surgical Research

Volumn 156, Issue 2, 2009, Pages 245-249

  Thatch, Keith A ^a   Mendelson, Kim G ^a   Haber, Marian M ^b   Schwartz, Marshall Z ^a,b  

^a ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

angiogenesis; growth factor; hepatocyte growth factor; inflammatory bowel disease; intestinal inflammation; microvascular density

Indexed keywords

GAMMA INTERFERON; HLA B27 ANTIGEN; INTERLEUKIN 2; RECOMBINANT SCATTER FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INFLAMMATORY INFILTRATE; INTESTINE BLOOD FLOW; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; TRANSGENIC RAT;

ANGIOGENESIS INDUCING AGENTS; ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; HEPATOCYTE GROWTH FACTOR; HLA-B27 ANTIGEN; INFLAMMATORY BOWEL DISEASES; INFUSIONS, INTRAVENOUS; INTESTINES; MICROCIRCULATION; NEOVASCULARIZATION, PHYSIOLOGIC; RATS; RATS, TRANSGENIC;

EID: 70249129719     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.01.036     Document Type: Article

References (21)

1. Danese S., Sans M., De La Motte C., et al. Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 130 (2006) 2060
2. Chidlow J.H., Shukla D., Grisham M.B., et al. Pathogenic angiogenesis in IBD and experimental colitis: New ideas and therapeutic avenues. Am J Physiol Gastrointest Liver Physiol 293 (2007) G5
3. Pousa I.D., Mate J., and Gisbert J.P. Angiogenesis in inflammatory bowel disease. Eur J Clin Invest 38 (2008) 73
4. Arthur L.G., Kuenzler K.A., and Schwartz M.Z. Hepatocyte growth factor ameliorates inflammatory bowel disease in a rat model. J Gastrointest Surg 7 (2003) 1062
5. Arthur L.G., Schwartz M.Z., Kuenzler K.A., et al. Hepatocyte growth factor treatment ameliorates diarrhea and bowel inflammation in a rat model of inflammatory bowel disease. J Pediatr Surg 39 (2004) 139
6. Kato Y., Yu D., and Schwartz M.Z. Enhancement of intestinal adaptation by hepatocyte growth factor. J Pediatr Surg 33 (1998) 235
7. Alavi K., Schwartz M.Z., Prasad R., et al. Novel use of hepatocyte growth factor in the treatment of inflammatory bowel disease. Surg Forum 50 (1999) 561
8. Kato Y., Yu D., and Schwartz M.Z. Hepatocyte growth factor up-regulates SGLT-1 and GLUT-5 gene expression after massive small bowel resection. J Pediatr Surg 33 (1998) 13
9. Beck P.L., and Podolsky D.K. Growth factors in inflammatory bowel disease. Inflamm Bowel Dis 5 (1999) 44
10. Weidner N. Current pathologic methods for measuring intratumoral, microvessel density within breast carcinoma and other solid tumors. Breast Cancer Res Treat 36 (1995) 169
11. Danese S., Sans M., Spencer D.M., et al. Angiogenesis blockade as a new therapeutic approach to experimental colitis. Gut 56 (2007) 855
12. Bagli E, Xagorari A, Papetropoulos A, et al. Angiogenesis in inflammation. Autoimmun Rev 2204;3(Suppl 1):S26.
13. Szekanecz Z., and Koch A.E. Vascular endothelium and immune responses: Implications for inflammation and angiogenesis. Rheum Dis Clin North Am 30 (2004) 97
14. Deban L., Correale C., Vetrano S., et al. Multiple pathogenic roles of microvasculature in inflammatory bowel disease: A jack of all trades. Am J Pathol 172 (2008) 1457
15. Romagnani P., Lasagni L., Annunziato F., et al. CXC chemokines: The regulatory link between inflammation and angiogenesis. Trends Immunol 25 (2004) 201
16. Erikson U., Fagerberg S., Krause U., et al. Angiographic studies in Crohn's disease and ulcerative colitis. Am J Roentgenol Radium Ther Nucl Med 110 (1970) 385
17. Hatoum O.A., Binion D.G., and Gutterman D.D. Paradox of simultaneous intestinal ischemia and hyperemia in inflammatory bowel disease. Eur J Clin Invest 35 (2005) 599
18. Jackson J.R., Seed M.P., Kircher C.H., et al. The codependence of angiogenesis and chronic inflammation. FASEB J 11 (1997) 457
19. Stokkers P.C., and Hommes D.W. New cytokine therapeutics for inflammatory bowel disease. Cytokine 28 (2004) 167
20. Ido A., Numata M., Kodama M., et al. Mucosal repair and growth factors: Recombinant human hepatocyte growth factor as an innovative therapy for inflammatory bowel disease. J Gastroenterol 40 (2005) 925
21. Tahara Y., Ido A., Yamamato S., et al. Hepatocyte growth factor facilitates colonic mucosal repair in experimental ulcerative colitis in rats. J Pharmacol Exp Ther 38 (2003) 837